Kenyan scientists on the verge of new Ebola Vaccines
Professor Aggrey Omu Anzala founding member of Kenya Aids Vaccine Initiative (Kenya Standard)
London, May 28, 2018 (AltAfrika)-A group of Kenyan researchers are on the verge of making history in the treatment of Ebola.
The researchers from the Kenya Medical Research Institute (Kemri) say they are confident that the two vaccines they have come up with could work against the deadly disease.
The vaccines, according to them are currently been tested for possible side effects in human beings.
According to the study’s associate investigator, Josephat Kosgei, “We want to investigate how the body’s immune system responds to the study vaccines,” Dr Kosgei told reporters during a visit to the study site in Kericho on Friday.
He said the second phase of the vaccine trial, which started In March 2017, enrolled 122 participants who received two vaccinations and that all the subjects were being followed up. “We have done six months visits. We are waiting for the last visit at one year, which will be six months from now, then data analysis will be done,”
He added that participants’ clinical evaluation included medical history and physical examination at every study visit.
A Kemri director at the Kericho site, Fredrick Sawe, said the study was a breakthrough in the search for an Ebola vaccine.
He said after the trials, which were at their tail end, it would be able to treat Ebola patients and prevent infection. “For you to know that the Ebola vaccine is working you need to give it to a community that has Ebola,” said Dr Sawe.
If successful, the vaccines will be a big breakthrough to the treatment of Ebola, a disease threatening to defy solutions. It would, more importantly be a local solution to a local problem, An African solution to African problem
The study was sponsored by Janssen Vaccines & Prevention B V, a company associated with Johnson & Johnson.